CANCON’s contribution to quality improvement in comprehensive cancer control: ECCO’s views Philip Poortmans & Ingrid van den Neucker ECCO Board Member & Oncopolicy Chair Head of External Relations Unit Stakeholder Forum, 15 September 2016

The European CanCer Organisation ECCO is a Federation 35 years old FECS: Federation of European Cancer Societies 2007 > ECCO 24 European member organisations Oncocommunity 80.000+ cancer professionals

Supporting ECCO’s vision, goals and objectives ECCO’s vision is to improve outcomes for all cancer patients in Europe through multidisciplinarity. The goals and objectives of the Organisation are to:  Provide a cohesive platform for European Cancer Societies and Organisations;  Work together to improve cancer treatment outcomes;  Be the unified voice of the European cancer community when addressing common policy issues. ECCO’s core goal that serves as a unifying focal point for all of its efforts is that:  ECCO seeks to address disparities in cancer outcomes across Europe by achieving synergies between different Members’ expertise and knowledge to ensure that the oncology value chain1 is optimised for all cancer patients.

Supporting ECCO’s vision, goals and objectives ECCO’s vision is to improve outcomes for all cancer patients in Europe through multidisciplinarity. The goals and objectives of the Organisation are to:  Provide a cohesive platform for European Cancer Societies and Organisations;  Work together to improve cancer treatment outcomes;  Be the unified voice of the European cancer community when addressing common policy issues. ECCO’s core goal that serves as a unifying focal point for all of its efforts is that:  ECCO seeks to address disparities in cancer outcomes across Europe by achieving synergies between different Members’ expertise and knowledge to ensure that the oncology value chain1 is optimised for all cancer patients.

Supporting ECCO’s vision, goals and objectives ECCO’s vision is to improve outcomes for all cancer patients in Europe through multidisciplinarity. The goals and objectives of the Organisation are to:  Provide a cohesive platform for European Cancer Societies and Organisations;  Work together to improve cancer treatment outcomes;  Be the unified voice of the European cancer community when addressing common policy issues. ECCO’s core goal that serves as a unifying focal point for all of its efforts is that:  ECCO seeks to address disparities in cancer outcomes across Europe by achieving synergies between different Members’ expertise and knowledge to ensure that the oncology value chain1 is optimised for all cancer patients.

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (Institute Of Medicine 2013) Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the begining what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Quality Cancer Care The degree to which cancer services increase the likelihood of desired health outcomes and are consistent with current professional knowledge (IOM 2013) Components according to ECCO: Engaged patients Adequately staffed, trained and coordinated workforce Evidence based cancer care A learning health care information technology system for cancer care Translation of evidence into practice, quality measurement and performance improvement Accessible and affordable cancer care Overview What are we talking about? Content State from the beginning what we understand by quality cancer care We use here the definition of the Institute of Medicine (IOM) (2013) – the same one used by the ECCO Board for the strategic renewal plan Key component of QCC – 6 elements In the following slides we will look at some of the challenges that they pose and the way CANCON adressed them (or not)

Key Challenges ECCO’s viewpoint as standard for HC professionals Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Key Challenges ECCO’s viewpoint as standard for HC professionals Changing medical care: Concentration/centralisation Personalised medicine Omics Complex process – coordination of levels of care, providers and health professionals Role of patients  – centricity / consumer/ advocate Quality of survival Inequalities – access/ affordability Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Key Challenges ECCO’s viewpoint as standard for HC professionals Changing medical care Coordination of complex processes:  Levels of care  Providers/institutions  Health professionals Role of patients  – centricity / consumer/ advocate Quality of survival Inequalities – access/ affordability Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Key Challenges ECCO’s viewpoint as standard for HC professionals Changing medical care Complex process – coordination of levels of care, providers and health professionals Role/position of patients:  Centricity  Consumer  Advocate Quality of survival Inequalities – access/ affordability Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Key Challenges ECCO’s viewpoint as standard for HC professionals Changing medical care Complex process – coordination of levels of care, providers and health professionals Role of patients  – centricity / consumer/ advocate Quality of survival: Rehabilitation Survivorship Oncogeriatrics Inequalities – access/ affordability Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Key Challenges ECCO’s viewpoint as standard for HC professionals Changing medical care Complex process – coordination of levels of care, providers and health professionals Role of patients  – centricity / consumer/ advocate Quality of survival Inequalities:  Access  Affordability Overview Here we should state ECCO’s views of the challenges – as there are many, I purposedly selected those that in a way or another have been touched upon by CANCON work This sets the scene for our comments: this slide sets the environment The next one states what HCP scientific societies and organisations are doing The following what CANCON has achieved The next steps Content Changing medical care (concentration vs decentralisation of complex treatments and procedures;Personalised medicine; omic revolution) Complex process – coordination of levels of care, providers and health professionals Patient centricity – patient consumer – patient advocate Quality of survival after curative treatment and while living with recurent disease - Oncogeriatrics, survivorship, rehabilitation. Cancer control planning shifts from « how long » people live after diagnosis to « how well » people can expect to live from diagnosis onwards, Inequalities (access, affordability)

Role of scientific societies / organisations Increase involvement in health care and its organisation  through our members Oncopolicy – united voice on common policy issues – critical mass New approaches in setting priorities Overview How does ECCO and its members societies contribute as scientific societies / organisations to improve quality cancer care? Follow concrete examples from ECCO member societies and in particular from ECCO Mention all of them but develop ECCO’s ERQCC work as an example of what our concrete policy contribution is in the area of quality improvement Content Increase involvement in health care and its organisation Oncopolicy – united voice on common policy issues – critical mass New approaches in setting priorities: ERQCC, HERO, Benefit scale

Role of scientific societies / organisations Increase involvement in health care and its organisation Oncopolicy – united voice on common policy issues – critical mass  all together New approaches in setting priorities Overview How does ECCO and its members societies contribute as scientific societies / organisations to improve quality cancer care? Follow concrete examples from ECCO member societies and in particular from ECCO Mention all of them but develop ECCO’s ERQCC work as an example of what our concrete policy contribution is in the area of quality improvement Content Increase involvement in health care and its organisation Oncopolicy – united voice on common policy issues – critical mass New approaches in setting priorities: ERQCC, HERO, Benefit scale

Role of scientific societies / organisations Increase involvement in health care and its organisation Oncopolicy – united voice on common policy issues – critical mass New approaches in setting priorities  all together  ERQCC  individual  HERO; Benefit Scale; … Overview How does ECCO and its members societies contribute as scientific societies / organisations to improve quality cancer care? Follow concrete examples from ECCO member societies and in particular from ECCO Mention all of them but develop ECCO’s ERQCC work as an example of what our concrete policy contribution is in the area of quality improvement Content Increase involvement in health care and its organisation Oncopolicy – united voice on common policy issues – critical mass New approaches in setting priorities: ERQCC, HERO, Benefit scale

CANCON’s contribution according to ECCO (1) Key achievements for the 4 chapters Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON’s contribution according to ECCO (1) Overall: consistent quality approach for National Cancer Control Programmes Cancer screening: National structures for governance; coordination and feedback, registration and monitoring Integrated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? Community level cancer care: diversity linked to national characteristics – blueprint for cancer patient pathway in after care at political agenda for discussion but far from implementation Survivorship and rehabilitation: common ground and will for implementing a comprehensive « Survivorship care plan » Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON’s contribution according to ECCO (1) Consistent quality approach for National Cancer Control Programmes Cancer screening: national structures for governance; coordination and feedback, registration and monitoring Integrated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? Community level cancer care: diversity linked to national characteristics – blueprint for cancer patient pathway in after care at political agenda for discussion but far from implementation Survivorship and rehabilitation: common ground and will for implementing a comprehensive « Survivorship care plan » Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON’s contribution according to ECCO (1) Consistent quality approach for National Cancer Control Programmes Cancer screening: National structures for governance; coordination and feedback, registration and monitoring Integrated cancer control: various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? Community level cancer care: diversity linked to national characteristics – blueprint for cancer patient pathway in after care at political agenda for discussion but far from implementation Survivorship and rehabilitation: common ground and will for implementing a comprehensive « Survivorship care plan » Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON’s contribution according to ECCO (1) Consistent quality approach for National Cancer Control Programmes Cancer screening: National structures for governance; coordination and feedback, registration and monitoring Integrated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? Community level cancer care: diversity linked to national characteristics – blueprint for cancer patient pathway in after care at political agenda for discussion but far from implementation Survivorship and rehabilitation: common ground and will for implementing a comprehensive « Survivorship care plan » Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON’s contribution according to ECCO (1) Consistent quality approach for National Cancer Control Programmes Cancer screening: National structures for governance; coordination and feedback, registration and monitoring Integrated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? Community level cancer care: diversity linked to national characteristics – blueprint for cancer patient pathway in after care at political agenda for discussion but far from implementation Survivorship and rehabilitation: common ground and will for implementing a comprehensive « Survivorship care plan » Overview This slide summarises the key achievement for each of the 4 chapters (remenber that the rest of the day will be dedicated to go into details of this so here you just want to give the top line recommendations from each of the chapters) Content Based on the recommendations proposed in each of the chapter –you could say that the contribution of CANCON has been: Overall - Consistent quality approach for National Cancer Control Programmes (continuation from EPAAC work) For chapter on Cancer screening: National structures for governance; coordination and feedback, registration and monitoring For chapter on Integated cancer control: Various valid examples exists at national level – many questions still remain - lack of common ground for practical implementation? For Community level cancer care: Case studies show diversity as they rely on specific national caracteristics – blueprint objective for cancer patient pathway in after care is a long way away but what matters is that we start putting it in the political agenda (refer to primary care track at ECCO 2017) For chapter on Survivorship and rehabilitation: the is clearly a common ground and will for a comprehensive « Survivorship care plan »

CANCON contribution according to ECCO (2) Concepts behind achievements of the 4 chapters Overview The idea is that the slide summarise the concepts behing what each of the 4 chapters have achieved (the concepts behind what you developped in your previous slide) Content Effort to share best practices and look for common viable solutions when possible – value of shared experience and learnings through comparative process All relevant parties sitting at the table openly discussing the challenges and opportunites from their perspective for improvement of cancer care – better understanding of others positions contribute to pave the way for improvement of the current situation – common understanding of challenges and expectations leads the way to practical implementation to improve outcomes Key issues addressed at the European political agenda – political momentum to improve outcomes at all levels

CANCON contribution according to ECCO (2) Value of shared experience and learning through comparative process Common ground and understanding to trigger practical implementation Political agenda setting both at European but also National level Overview The idea is that the slide summarise the concepts behing what each of the 4 chapters have achieved (the concepts behind what you developped in your previous slide) Content Effort to share best practices and look for common viable solutions when possible – value of shared experience and learnings through comparative process All relevant parties sitting at the table openly discussing the challenges and opportunites from their perspective for improvement of cancer care – better understanding of others positions contribute to pave the way for improvement of the current situation – common understanding of challenges and expectations leads the way to practical implementation to improve outcomes Key issues addressed at the European political agenda – political momentum to improve outcomes at all levels

CANCON contribution according to ECCO (2) Value of shared experience and learning through comparative process Common ground and understanding to trigger practical implementation Political agenda setting both at European but also National level Overview The idea is that the slide summarise the concepts behing what each of the 4 chapters have achieved (the concepts behind what you developped in your previous slide) Content Effort to share best practices and look for common viable solutions when possible – value of shared experience and learnings through comparative process All relevant parties sitting at the table openly discussing the challenges and opportunites from their perspective for improvement of cancer care – better understanding of others positions contribute to pave the way for improvement of the current situation – common understanding of challenges and expectations leads the way to practical implementation to improve outcomes Key issues addressed at the European political agenda – political momentum to improve outcomes at all levels

CANCON contribution according to ECCO (2) Value of shared experience and learning through comparative process Common ground and understanding to trigger practical implementation Political agenda setting both at European but also National level Overview The idea is that the slide summarise the concepts behing what each of the 4 chapters have achieved (the concepts behind what you developped in your previous slide) Content Effort to share best practices and look for common viable solutions when possible – value of shared experience and learnings through comparative process All relevant parties sitting at the table openly discussing the challenges and opportunites from their perspective for improvement of cancer care – better understanding of others positions contribute to pave the way for improvement of the current situation – common understanding of challenges and expectations leads the way to practical implementation to improve outcomes Key issues addressed at the European political agenda – political momentum to improve outcomes at all levels

= on the road to become a very valuable instrument Way forward = on the road to become a very valuable instrument Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

 Collaboration with all stakeholders Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy  Collaboration with all stakeholders Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control ERN as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control  As a professional/scientific organisation: evidence based & multidisciplinary ERN as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control European Reference Networks as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control ERN as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control ERN as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Way forward Continued support of ECCO and its members societies in improving quality cancer care through multidisciplinarity and oncopolicy Continue to inform policy-makers positions to facilitate change to the organisation and structure of health systems to support cancer control ERN as a way of promoting cooperation amongst clinicians and hospitals for patient care as well as to share knowledge, expertise and improve outcomes Workforce: training (both knowledge & skills – e.g. CANMEDS), cross border mobility Collaboration to bring research outcomes into clinical practice This European cooperation involving all stakeholders needs to be continued and reinforced – ECCO is ready to contribute! Overview Way forward from ECCO’s perspective, Expectations for final conference and period following the end of the Joint Action Content Challenge to pursue a consistent methodological approach to improve quality cancer care will remain. However elements have been brought forward and will be discussed in detail during the day Specifically as a way forward: see proposed bullet points ERN = >European Reference Networks : ECCO is participating to the one organised by Jean-Yves Blay (Lyon) on adults rare cancers… (details are still to be defined) Strong message that the kind of cooperation at the European level that involves all stakeholders needs to be continued and reinforced

Remark I know this is purely promotion but to be honest we will adress most of those issues in some way at the congress so the congress should be positioned for this audience as the yearly platform for continuing the debate with the healthcare professionals… Content ECCO2017 European CanCer Congress 27 – 30 January Amsterdam, The Nederlands Is the organisation’s platform to disseminate and debate Present latest science to a multidisciplinary audience Debate evidence and determine real impact on clinical practice Discuss and compile multidisciplinary policy based on evidence Shape the future of oncopolicy in Europe